$SCPX
Scorpius Holdings, Inc. Stock $scpx

$scpx Overview Financials Valuation SEC Filings Company Website

2015 Q4 Form 10-Q Financial Statement

#000155335015001129 Filed on October 30, 2015

Income Statement

Concept	2015 Q4	2015 Q3	2015 Q1
Revenue	$0.00	$0.00	$9.126K
YoY Change		-100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.210M	$950.0K	$1.310M
YoY Change	7.08%	14.46%	29.7%
% of Gross Profit
Research & Development	$830.0K	$677.2K	$503.6K
YoY Change	88.64%	-33.96%	-5.64%
% of Gross Profit
Depreciation & Amortization	$40.00K	$30.44K	$25.61K
YoY Change	33.33%	32.61%	1080.28%
% of Gross Profit
Operating Expenses	$6.840M	$5.343M	$3.982M
YoY Change	84.86%	71.48%	66.28%
Operating Profit		-$5.343M	-$3.982M
YoY Change		71.48%	66.28%
Interest Expense	-$90.00K	$108.8K	$50.39K
YoY Change	80.0%	1237.36%
% of Operating Profit
Other Income/Expense, Net	$170.0K	-$84.26K	-$44.69K
YoY Change	750.0%	655.05%	59.12%
Pretax Income	-$6.760M	-$5.430M	-$4.030M
YoY Change	81.23%	73.48%	66.53%
Income Tax
% Of Pretax Income
Net Earnings	-$6.490M	-$5.185M	-$3.909M
YoY Change	79.78%	72.83%	67.73%
Net Earnings / Revenue			-42835.83%
Basic Earnings Per Share
Diluted Earnings Per Share	-$54.08	-$43.25	-$39.10
COMMON SHARES
Basic Shares Outstanding	8.415M shares	8.405M shares	8.394M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2015 Q4	2015 Q3	2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$11.60M	$15.00M	$21.10M
YoY Change	-19.44%	-2.6%	8.76%
Cash & Equivalents	$4.900M	$8.211M	$10.27M
Short-Term Investments	$6.700M	$6.700M	$10.80M
Other Short-Term Assets	$900.0K	$1.000M	$1.100M
YoY Change	0.0%	66.67%	22.22%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$12.50M	$15.94M	$22.15M
YoY Change	-18.18%	-0.92%	8.94%
LONG-TERM ASSETS
Property, Plant & Equipment	$400.0K	$468.0K	$428.2K
YoY Change	-10.22%	0.79%	654.7%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$200.0K	$254.3K	$251.5K
YoY Change	3.03%	38.64%	2279.3%
Total Long-Term Assets	$700.0K	$722.3K	$679.7K
YoY Change	9.43%	11.51%	909.87%
TOTAL ASSETS
Total Short-Term Assets	$12.50M	$15.94M	$22.15M
Total Long-Term Assets	$700.0K	$722.3K	$679.7K
Total Assets	$13.20M	$16.66M	$22.83M
YoY Change	-17.07%	-0.44%	11.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.000M	$936.4K	$819.9K
YoY Change	46.26%	37.6%	116.69%
Accrued Expenses	$1.800M	$2.074M	$724.5K
YoY Change	123.33%	364.89%	91.43%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.100M	$2.100M	$700.0K
YoY Change	675.0%	2000.0%
Total Short-Term Liabilities	$7.000M	$5.064M	$2.248M
YoY Change	172.28%	303.0%	196.98%
LONG-TERM LIABILITIES
Long-Term Debt	$3.600M	$2.800M	$2.000M
YoY Change	56.52%	154.55%
Other Long-Term Liabilities	$100.0K	$12.23K
YoY Change
Total Long-Term Liabilities	$3.700M	$12.23K	$2.000M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.000M	$5.064M	$2.248M
Total Long-Term Liabilities	$3.700M	$12.23K	$2.000M
Total Liabilities	$9.100M	$7.908M	$4.279M
YoY Change	86.29%	241.59%	465.37%
SHAREHOLDERS EQUITY
Retained Earnings		-$37.94M
YoY Change
Common Stock		$1.365K	$1.361K
YoY Change		39.43%	39.59%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.100M	$10.03M	$19.40M
YoY Change
Total Liabilities & Shareholders Equity	$13.20M	$16.66M	$22.83M
YoY Change	-17.07%	-0.44%	11.92%

Cashflow Statement

Concept	2015 Q4	2015 Q3	2015 Q1
OPERATING ACTIVITIES
Net Income	-$6.490M	-$5.185M	-$3.909M
YoY Change	79.78%	72.83%	67.73%
Depreciation, Depletion And Amortization	$40.00K	$30.44K	$25.61K
YoY Change	33.33%	32.61%	1080.28%
Cash From Operating Activities	-$5.070M	-$4.170M	-$4.462M
YoY Change	104.44%	46.32%	86.63%
INVESTING ACTIVITIES
Capital Expenditures	$10.00K	$10.00K	$8.280K
YoY Change	0.0%		60.62%
Acquisitions
YoY Change
Other Investing Activities	$20.00K	$1.120M	-$110.0K
YoY Change	-98.55%	-186.82%	-122.92%
Cash From Investing Activities	$0.00	$1.130M	-$114.2K
YoY Change	-100.0%	-187.6%	-123.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$11.10M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.810M	-140.0K	$11.13M
YoY Change	17.53%	-109.79%	30204.58%
NET CHANGE
Cash From Operating Activities	-5.070M	-4.170M	-$4.462M
Cash From Investing Activities	0.000	1.130M	-$114.2K
Cash From Financing Activities	1.810M	-140.0K	$11.13M
Net Change In Cash	-3.260M	-3.180M	$6.553M
YoY Change	-840.91%	17.34%	-449.19%
FREE CASH FLOW
Cash From Operating Activities	-$5.070M	-$4.170M	-$4.462M
Capital Expenditures	$10.00K	$10.00K	$8.280K
Free Cash Flow	-$5.080M	-$4.180M	-$4.471M
YoY Change	104.02%	46.67%	86.58%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3714304	USD
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2015-09-30
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Entity Registrant Name EntityRegistrantName	HEAT BIOLOGICS, INC.
	dei	Entity Central Index Key EntityCentralIndexKey	0001476963
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2014Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	2314124	USD
CY2015Q3	us-gaap	Liabilities Liabilities	7908409	USD
CY2014Q4	us-gaap	Liabilities Liabilities	4884983	USD
CY2015Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	11100000	USD
	dei	Trading Symbol TradingSymbol	HTBX
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	11400870	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		USD
CY2015Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	628826	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	521988	USD
CY2015Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	160827	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	76454	USD
CY2015Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	467999	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	445534	USD
CY2015Q3	us-gaap	Depreciation Depreciation	30436	USD
CY2014Q3	us-gaap	Depreciation Depreciation	22952	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	15276513	USD
CY2015Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	101146	USD
CY2014Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	101129	USD
CY2015Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	69798	USD
CY2014Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	19798	USD
CY2015Q3	us-gaap	Due From Related Parties Noncurrent DueFromRelatedPartiesNoncurrent	58017	USD
CY2014Q4	us-gaap	Due From Related Parties Noncurrent DueFromRelatedPartiesNoncurrent	48642	USD
CY2015Q3	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	25379	USD
CY2014Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	24554	USD
CY2015Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	254340	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	194123	USD
CY2015Q3	us-gaap	Assets Assets	16662528	USD
CY2014Q4	us-gaap	Assets Assets	15916170	USD
CY2015Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	936361	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1367426	USD
CY2015Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2074174	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	805968	USD
CY2015Q3	us-gaap	Notes Payable Current NotesPayableCurrent	2053859	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8210938	USD
CY2014Q4	us-gaap	Notes Payable Current NotesPayableCurrent	397465	USD
CY2015Q3	us-gaap	Liabilities Current LiabilitiesCurrent	5064394	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2570859	USD
CY2015Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	2831787	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24135447	USD
CY2015Q3	us-gaap	Stockholders Equity StockholdersEquity	10032480	USD
CY2015Q3	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	6742987	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	11760358	USD
CY2015Q3	us-gaap	Minority Interest MinorityInterest	-1278361	USD
CY2014Q4	us-gaap	Minority Interest MinorityInterest	-729171	USD
CY2015Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8754119	USD
CY2015Q3	us-gaap	Common Stock Value CommonStockValue	1365	USD
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	982	USD
CY2015Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-64238	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax		USD
CY2015Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	48038935	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	35894823	USD
CY2015Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-37943582	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	11031187	USD
CY2015Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16662528	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15916170	USD
CY2014Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	10698982	USD
CY2015Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	986264	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	863227	USD
CY2015Q3	us-gaap	Assets Current AssetsCurrent	15940189	USD
CY2015Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	12228	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent		USD
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.04
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.97
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	6.50
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	75818	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	13848	USD
	us-gaap	Depreciation Depreciation	84373	USD
	us-gaap	Depreciation Depreciation	41850	USD
CY2015Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	92233	USD
CY2014Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	519092	USD
CY2015Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	35000	USD
CY2014Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	40000	USD
CY2015Q3	us-gaap	Accrued Rent Current AccruedRentCurrent	54957	USD
CY2014Q4	us-gaap	Accrued Rent Current AccruedRentCurrent	51155	USD
CY2015Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	836333	USD
CY2014Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent		USD
CY2015Q3	htbx	Accrued Clinical Trial Expense Current AccruedClinicalTrialExpenseCurrent	1055651	USD
CY2014Q4	htbx	Accrued Clinical Trial Expense Current AccruedClinicalTrialExpenseCurrent	195721	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1767942	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2425404	USD
	htbx	Clinical And Regulatory Expense ClinicalAndRegulatoryExpense	9261529	USD
	htbx	Clinical And Regulatory Expense ClinicalAndRegulatoryExpense	3218137	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3150394	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2844883	USD
	us-gaap	Operating Expenses OperatingExpenses	14179865	USD
	us-gaap	Operating Expenses OperatingExpenses	8488424	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-14179865	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8488424	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	49970	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	27261	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	29909	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-242244	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-39291	USD
	us-gaap	Interest Expense InterestExpense	257339	USD
	us-gaap	Interest Expense InterestExpense	8138	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-177460	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-20168	USD
	us-gaap	Profit Loss ProfitLoss	-14357325	USD
	us-gaap	Profit Loss ProfitLoss	-8508592	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-549190	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-330675	USD
	us-gaap	Net Income Loss NetIncomeLoss	-13808135	USD
	us-gaap	Net Income Loss NetIncomeLoss	-8177917	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.75
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.27
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	7880637	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	6445129	shares
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-64238	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax		USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-14421563	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-8508592	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-549190	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-330675	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13872373	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8177917	USD
CY2015Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	677151	USD
CY2014Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1025442	USD
CY2015Q3	htbx	Clinical And Regulatory Expense ClinicalAndRegulatoryExpense	3718902	USD
CY2014Q3	htbx	Clinical And Regulatory Expense ClinicalAndRegulatoryExpense	1258566	USD
CY2015Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	947392	USD
CY2014Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	832101	USD
CY2015Q3	us-gaap	Operating Expenses OperatingExpenses	5343445	USD
CY2014Q3	us-gaap	Operating Expenses OperatingExpenses	3116109	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5343445	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3116109	USD
CY2015Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	20121	USD
CY2014Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	9740	USD
CY2015Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4449	USD
CY2014Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-12762	USD
CY2015Q3	us-gaap	Interest Expense InterestExpense	108834	USD
CY2014Q3	us-gaap	Interest Expense InterestExpense	8138	USD
CY2015Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-84264	USD
CY2014Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-11160	USD
CY2015Q3	us-gaap	Profit Loss ProfitLoss	-5427709	USD
CY2014Q3	us-gaap	Profit Loss ProfitLoss	-3127269	USD
CY2015Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-242244	USD
CY2014Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-126865	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	-5185465	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	-3000404	USD
CY2015Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.62
CY2014Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.46
CY2015Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	8408376	shares
CY2014Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	6469272	shares
CY2015Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-27244	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax		USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-5454953	USD
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-3127269	USD
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-126865	USD
	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments	13827773	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5212709	USD
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3000404	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1046086	USD
	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	302461	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-64238	USD
	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	102618	USD
	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	137897	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	7263	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1046086	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	722358	USD
	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	9375	USD
	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	18446	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	157440	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-318275	USD
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	50000	USD
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	10478	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-385161	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	28561	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	1260355	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-56888	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet		USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-25364	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-12377823	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-7349716	USD
	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments	14943468	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	11090091	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	8783623	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	106838	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	452444	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	3746539	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	4591706	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	11400870	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	37719	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	302461	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	13195823	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	1473002	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-67905	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents		USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	4496634	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1285008	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4566992	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3281984	USD
	us-gaap	Interest Paid InterestPaid	257339	USD
	us-gaap	Interest Paid InterestPaid	8138	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	12228	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities		USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	2242575	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1435283	USD
	htbx	Cashless Exercise Of Stock Warrants CashlessExerciseOfStockWarrants		USD
	htbx	Cashless Exercise Of Stock Warrants CashlessExerciseOfStockWarrants	452874	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	145161	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt		USD
CY2015Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	6.50
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.10
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.33
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	3.89
CY2015Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	3114452	USD
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.89
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	649421	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	649421	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1106895	shares
CY2015Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	1640000	shares
CY2015Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	8415434	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	179298	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	10272	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	277875	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1018590	shares
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0002
CY2015Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8415434	shares
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6492622	shares
CY2015Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0002
CY2015Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2015Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8415434	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6492622	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.8362	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0163	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y4M24D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P6Y2M12D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y2M12D
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P15M24D

Files In Submission

Name	View Source	Status
0001553350-15-001129-index-headers.html	Edgar Link	pending
0001553350-15-001129-index.html	Edgar Link	pending
0001553350-15-001129.txt	Edgar Link	pending
0001553350-15-001129-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
htbx-20150930.xml	Edgar Link	completed
htbx-20150930.xsd	Edgar Link	pending
htbx-20150930_cal.xml	Edgar Link	unprocessable
htbx-20150930_def.xml	Edgar Link	unprocessable
htbx-20150930_lab.xml	Edgar Link	unprocessable
htbx-20150930_pre.xml	Edgar Link	unprocessable
htbx_10q.htm	Edgar Link	pending
htbx_ex31z1.htm	Edgar Link	pending
htbx_ex31z2.htm	Edgar Link	pending
htbx_ex32z1.htm	Edgar Link	pending
htbx_ex32z2.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SCPX
Scorpius Holdings, Inc. Stock $scpx

2015 Q4 Form 10-Q Financial Statement

#000155335015001129 Filed on October 30, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCPX Scorpius Holdings, Inc. Stock $scpx

2015 Q4 Form 10-Q Financial Statement

#000155335015001129 Filed on October 30, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCPX
Scorpius Holdings, Inc. Stock $scpx